A 52-Year-old Man with Cough, Dyspnea, and Diffuse Parenchymal Lung Disease for 5 Years
Yan Li,Yongsheng Wang,Liyun Miao,Pinhao Xie,Hourong Cai
DOI: https://doi.org/10.1016/j.chest.2019.11.038
IF: 9.6
2020-01-01
Chest
Abstract:Case PresentationA 52-year-old man presented with repeated cough and worsening exertional dyspnea for 5 years. Long-term oral prednisone had been administered with little effect. He denied chest pain, hemoptysis, or nighttime paroxysmal dyspnea. His medical history included chronic hepatitis B, liver cirrhosis, splenomegaly, diabetes insipidus, and hypertension. He denied consuming alcohol or illicit drugs. He was a never smoker. His family history was noncontributory. A 52-year-old man presented with repeated cough and worsening exertional dyspnea for 5 years. Long-term oral prednisone had been administered with little effect. He denied chest pain, hemoptysis, or nighttime paroxysmal dyspnea. His medical history included chronic hepatitis B, liver cirrhosis, splenomegaly, diabetes insipidus, and hypertension. He denied consuming alcohol or illicit drugs. He was a never smoker. His family history was noncontributory. The patient’s vital signs on admission were as follows: oral temperature 36.2°C, heart rate 93 beats/min, BP 199/117 mm Hg, respiratory rate 22 breaths/min, and oxygen saturation 90% on room air. He was alert, oriented, and in moderate respiratory distress. There was no palpable lymphadenopathy. A few faint crackles were present at both lung bases. Heart rate was normal sinus rhythm without murmurs. The abdomen was soft without tenderness. The spleen was palpated approximately 2 cm under the rib cage. There was obvious clubbing and mild depression edema of both lower limbs. The remainder of the examination was unremarkable. The patient had multiple examinations prior to presenting for admission to our hospital. His initial chest CT scan 5 years before showed interlobular septal thickening, diffuse ground-glass opacities, and multiple micronodules (Fig 1). An ultrasound 6 months prior to admission showed liver cirrhosis and an enlarged spleen. A pulmonary function test 4 months before showed very severe mixed obstruction and restriction patterns; the diffusing capacity was unable to be completed (FVC was 0.99 L [23.0% predicted] and FEV1 was 0.67 L [19.4% predicted]). After admission to our hospital, the patient’s laboratory results were as follows: routine blood test: WBC count 6,700 cells/μL, neutrophil count 78.5%↑ (above normal limit), hemoglobin level 14.4 g/dL, and platelet count 160,000/μL; liver function: alanine aminotransferase level 42.8 U/L↑ and albumin level 34.3 g/L↓ (below normal limit); plasma immunoglobulin: IgA 3.64 g/L↑ (normal range, 0.7-3.3 g/L) with IgG, IgM, and IgE within normal ranges; communicable diseases screening: hepatitis B surface antigen (+), anti-hepatitis B e-antigen antibody (+), hepatitis C antibody (–), and HIV antibody (–); and arterial blood gas (room air): pH 7.401, Pco2 57.5 mm Hg, PO2 52 mm Hg, and oxygen saturation 85%. The following tests were within normal ranges: routine urine, routine stool, C-reactive protein, erythrocyte sedimentation rate, kidney function, blood coagulation function, serum angiotensin-converting enzyme, antinuclear antibodies, anti-double stranded DNA antibodies, antineutrophil cytoplasmic antibodies, hepatitis B virus DNA, and urine protein electrophoresis. ECG showed a normal sinus rhythm and a leftward axis. Echocardiogram showed left atrial enlargement; mild to moderate regurgitation of the tricuspid, mitral, and aortic valves; moderate pulmonary hypertension (50 mm Hg); left ventricular diastolic dysfunction; and left ventricular ejection fraction of 60%. Chest high-resolution CT scan performed on admission to our hospital showed diffuse ground-glass opacities, micronodules, and thickening of the interlobular septa, pleura, and interlobular fissure, which was more severe than it had been 5 years prior (Fig 1). Lymphadenopathy was not observed. Because of respiratory failure, poor lung function, and poor performance status, the patient was considered not suitable for transbronchial lung biopsy or surgical lung biopsy. To establish a definite diagnosis, what diagnostic test should be conducted? What is the diagnosis? Answer: Bone marrow aspiration and biopsy were performed, and lipid-laden foamy histiocytes with the characteristics of Niemann-Pick cells were observed (Fig 2) Diagnosis: Adult-onset Niemann-Pick disease type B Niemann-Pick disease (NPD) is a rare lysosomal storage disorder that was first reported by Niemann and Pick in 1914 and 1922, respectively. The incidence of this disease in newborns is 0.4 to 1.0 cases per 100,000 people without a sex predilection. It can be divided into three subtypes: type A, B, and C. Loss-of-function mutations in the SMPD1 gene are the cause of NPD types A and B, which have an autosomal recessive pattern of inheritance. Type C is caused by a different genetic alteration in the NPC1 or NPC2 genes. The SMPD1 gene is composed of six exons and is located on chromosome 11p15.1-11p15.4, encoding the lipid hydrolase enzyme acid sphingomyelinase (ASM). ASM is responsible for hydrolyzing sphingomyelin (SM) to ceramide and phosphocholine. ASM deficiency causes the intracellular accumulation of SM within the reticuloendothelial cells of the liver, spleen, lungs, bone marrow, or brain. The foamy histiocytes with cytoplasm containing numerous droplets of SM are called Niemann-Pick cells. Mutations in the SMPD1 gene cause deficient activity of ASM, leading to type A or type B NPD. Type A NPD is an infantile neurodegenerative disorder that occurs more frequently among individuals of Ashkenazi Jewish descent. The clinical presentation shows an early, severe, and rapid course that leads to death in the first few years of life. Type B NPD is a chronic visceral disorder without or with mild neurologic involvement. Patients with type B NPD can survive into adulthood and are characterized by prominent hepatosplenomegaly. The accumulation of Niemann-Pick cells in various tissues causes variable manifestations. Pulmonary involvement can occur in all three types of NPD but is most frequently found in type B. Most pulmonary involvement is clinically asymptomatic and detected on chest radiograph. Because it is slow progressing, patients present with nonspecific respiratory symptoms such as cough and dyspnea. The manifestations on chest CT scan are usually a reticulonodular pattern with interlobular septal thickening, ground-glass opacities, and multiple millimeter- and submillimeter-sized nodules. Lung biopsy of NPD pulmonary involvement could show foamy histiocyte infiltration in alveoli that stain sea blue with May-Grünwald-Giemsa. Electron microscopy examination shows sea blue histiocytes with dense granules in the cytoplasm, corresponding to secondary lysosomes with abundant myelin. Fibrosis of alveolar walls and interlobular septa might occur. Pulmonary function test usually shows a progressively worsening restrictive pattern. When complicated with secondary respiratory infection and excessive airway secretions, it may also show an obstructive pattern. The incidental radiographic finding of lung infiltration in the absence of other signs of disease in an adult is rarely recognized as a manifestation of NPD, especially if not previously diagnosed. Patients with mild symptoms are most often treated as having common respiratory diseases. A definitive diagnosis of NPD requires the presence of Niemann-Pick cells or the demonstration of reduced ASM activity. Niemann-Pick cells are 20 to 100 μm in diameter, small eccentric nuclear, mostly mononuclear, occasionally dinuclear, rich cytoplasm filled with lipid droplets. They can be detected in bone marrow aspirate, liver biopsy, spleen biopsy, lymph node biopsy, BAL fluid, or lung biopsy. Reduced ASM activity can be demonstrated in isolated peripheral blood leukocytes or cultured skin fibroblasts. Genetic analysis of mutations in the SMPD1 gene can assist the diagnosis. Genomic DNA can be extracted from the patients’ leukocytes or cultured fibroblasts. There is currently no specific treatment available for NPD. Some treatment alternatives might be useful and promising, such as hematopoietic stem cell transplantation, bone marrow transplantation, amniotic epithelial cell implantation, enzyme replacement therapy, and gene therapy. A lipid-poor diet may be effective for hyperlipidemia in NPD. Adult patients with nonneuronal NPD with hypersplenism can undergo splenectomy. Regarding pulmonary involvement, oxygen supplementation can be provided if respiratory failure is present. Whole lung lavage can be performed if bilateral lung involvement is present. The prognosis of patients with type B NPD is better than that of patients with type A or type C NPD. Pulmonary involvement is an important cause of morbidity and mortality in adult patients affected by type B NPD. Most patients die of recurrent respiratory infections. The patient had been uninterruptedly administering oral prednisone since disease onset but with little effect; therefore, sarcoidosis or hypersensitivity pneumonitis was excluded. The manifestation of interlobular septal thickening on the patient’s chest CT scan was noticed. The differential diagnoses regarding the predominant interlobular septal thickening pattern on chest CT scan included the following: hydrostatic pulmonary edema, lymphangitic carcinomatosis, sarcoidosis, NPD, Erdheim-Chester disease, cystic lymphangiectasia, and pulmonary lymphangiomatosis. The patient had medical history of diabetes insipidus, suggesting involvement of the pituitary gland, which can occur as a consequence of histiocytosis. Hence, NPD as one type of histiocytosis was suspected. Considering bone marrow can be infiltrated in NPD, bone marrow aspiration and biopsy were conducted and Niemann-Pick cells were identified. Total DNA from the patient’s peripheral blood was further extracted to amplify and sequence the SMPD1 gene. A previously unreported variant in exon 2 (c.1001T > C, p.I334T) was identified, as indicated in Figure 3. It is a missense mutation. The diagnosis was eventually confirmed. Because the ASM activity test cannot yet be performed in our hospital, the patient did not receive this test. He returned to a local clinic for palliative treatment and died 1 year later. 1.NPD is a rare inherited autosomal recessive disorder. Pulmonary involvement in NPD is a common finding, especially in type B disease; however, making a diagnosis of NPD because of pulmonary symptoms is unusual.2.The diagnosis of NPD can be confirmed by bone marrow, lung, liver, spleen, lymph node biopsy, or BAL fluid with findings of accumulation of finely vacuolated, foamy, lipid-filled macrophages which are called Niemann-Pick cells.3.There is currently no effective treatment available for NPD. Whole lung lavage may improve lung function temporarily, but does not alter the progress of the disease. Financial/nonfinancial disclosures: None declared. Role of sponsors: The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript. Other contributions: CHEST worked with the authors to ensure that the Journal policies on patient consent to report information were met.